Aphea.Bio is a synthetic biology company making agricultural biologicals that is headquartered in Ghent, Belgium and was founded in 2017 by Isabel Vercauteren. The company spun out of the Vlaams Instituut voor Biotechnologie (VIB) life sciences research institute and its partner universities UGent and KU Leuven.
The companies products are synthetically made naturally occurring substances produced in nature by microorganisms and plants that improve the health and yield of crops. Aphea.Bio is focused on developing biocontrol and biostimulant products for wheat and maize using their research and development platform capable of strain identification, strain isolation, strain validation, and product development.
On June 26, 2017 Aphea.Bio completed their series A funding round with $10 million in funding from V-Bio Ventures (lead investor), PMV, Agri Investment Fund, VIVES, Qbic II, Gemma Frisius Fund KU Leuven, Group De Ceuster and Vlaams Instituut voor Biotechnologie (VIB). Part of the companies series A funding round came from a local research and development grant; €7.7 million came from investors.